Vertebroplasty and Kyphoplasty Needles Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Global Vertebroplasty and Kyphoplasty Needles
Market Research and Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Vertebroplasty and Kyphoplasty Needles
  Market Global Industry Trends, Share, Size,
  Growth, Opportunity and Forecast
  2024-2032," the global vertebroplasty and
  kyphoplasty needles market size reached US 884.0
  Million in 2023.
• Factors Affecting the Growth of the
  Vertebroplasty and Kyphoplasty Needles Industry
• Increasing Prevalence of Osteoporosis and
  Vertebral Compression Fractures
• The rising occurrence of osteoporosis and
  vertebral compression fractures among the masses
  is propelling the market growth. These
  conditions, primarily affecting the elderly
  population, are driving the demand for minimally
  invasive (MI) surgical procedures, such as
  vertebroplasty and kyphoplasty.
• These procedures are favored for their benefits
  in pain relief and spinal stabilization, making
  them crucial in the management of osteoporotic
  fractures. This is supported by healthcare
  initiatives focused on bone health and the
  prevention of fractures, emphasizing the
  importance of early intervention and the adoption
  of effective treatment modalities like
  vertebroplasty and kyphoplasty.

4
Report Highlight and Description

• Technological Advancements in Surgical Equipment
• Innovations in needle design and functionality,
  such as improved precision, biocompatibility, and
  the introduction of materials that enhance
  durability and performance, are contributing to
  the effectiveness and safety of vertebroplasty
  and kyphoplasty procedures. These advancements
  facilitate easier navigation through the
  vertebral body, reducing procedure time and
  enhancing patient outcomes.
• Additionally, the integration of imaging
  techniques with surgical instruments is improving
  the accuracy of needle placement, minimizing
  complications and promoting faster recovery.
  Manufacturers are continuously investing in
  research and development (RD), which is
  resulting in the introduction of more
  sophisticated solutions, further driving adoption
  among healthcare providers.
• Growing Awareness and Acceptance of Minimally
  Invasive (MI) Procedures
• The increasing awareness and acceptance of
  minimally invasive (MI) procedures among both
  healthcare professionals and patients is offering
  a favorable market outlook. MI spine surgeries,
  including vertebroplasty and kyphoplasty, offer
  numerous advantages over traditional open
  surgeries, such as reduced pain, lower risk of
  infection, shorter hospital stays, and quicker
  recovery times.

5
Report Highlight and Description

• This shift towards less invasive treatment
  options is supported by a growing body of
  clinical evidence demonstrating their efficacy
  and safety in managing vertebral compression
  fractures. Healthcare systems worldwide are
  adopting these techniques, driven by patient
  preference for less invasive interventions and
  the potential for cost savings.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/vertebroplasty-kyphopla
  sty-needles-market/requestsample

6
Report Description

• Global Vertebroplasty and Kyphoplasty Needles
  Market Trends
• The growing integration of smart technologies and
  digital health solutions to enhance procedural
  outcomes and patient experiences is positively
  influencing the market. This includes the
  development of needles equipped with sensors and
  connectivity features that can provide real-time
  feedback on the placement and cement distribution
  during procedures.
• Additionally, the use of artificial intelligence
  (AI) and machine learning (ML) algorithms for
  predictive analytics in patient selection and
  procedural planning is gaining traction. These
  technologies can help in identifying patients who
  are most likely to benefit from vertebroplasty or
  kyphoplasty, thereby optimizing treatment
  outcomes and reducing the risk of complications.
• Looking forward, the market to reach US 1,334.2
  Million by 2032, exhibiting a growth rate (CAGR)
  of 4.68 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/vertebroplasty-kyphopla
  sty-needles-market

7
Report Segmentation

• Breakup by Procedure
• Kyphoplasty Procedures
• Vertebroplasty Procedures
• Breakup by End Use
• Hospitals
• Ambulatory Surgical Centers
• Breakup by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

8
Competitive Landscape with Key Players

• Adroit Manufacturing Company
• Biopsybell S.R.L. Società Unipersonale
• IZI Medical Products (Halma plc)
• Jayon Implants Pvt.Ltd.
• Medtronic Plc
• Merit Medical Systems, Inc.
• MOLLER Medical GmbH
• Stryker Corporation
• Suretech Medical INC
• Swastik Enterprise
• Tecres S.p.A.
• Teknimed

9
Key Questions Answered in the Report
10
Key Questions Answered in the Report
11
Table of Contents

• 1    Preface2 Scope and Methodology
• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
• 2.3.1 Primary Sources
• 2.3.2 Secondary Sources
• 2.4 Market Estimation
• 2.4.1 Bottom-Up Approach
• 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology
• 3 Executive Summary
• 4 Global Vertebroplasty and Kyphoplasty Needles
  Market - Introduction
• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence
• 5 Global Vertebroplasty and Kyphoplasty Needles
  Market Landscape
• 5.1 Historical and Current Market Trends
  (2018-2023)
• 5.2 Market Forecast (2024-2032)

12
Table of Contents

• 6.2.3 Market Segmentation
• 6.2.3.1 Directional Vertebroplasty Needles
• 6.2.3.2 Straight Vertebroplasty Needles
• 6.2.4 Market Forecast (2024-2032)
• 6.3 Attractive Investment Proposition by
  Procedure
• 7 Global Vertebroplasty and Kyphoplasty Needles
  Market - Breakup by End Use
• 7.1 Hospitals
• 7.1.1 Overview
• 7.1.2 Historical and Current Market Trends
  (2018-2023)
• 7.1.3 Market Segmentation
• 7.1.4 Market Forecast (2024-2032)
• 7.2 Ambulatory Surgical Centers
• 7.2.1 Overview
• 7.2.2 Historical and Current Market Trends
  (2018-2023)
• 7.2.3 Market Segmentation
• 7.2.4 Market Forecast (2024-2032)
• 7.3 Attractive Investment Proposition by End Use
• 8 Global Vertebroplasty and Kyphoplasty Needles
  Market Breakup by Region
• 8.1 North America

13
Partial List of Clients
14
Partial List of Clients
15
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

16
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us